PB1945 EXPERIENCE OF THE ANDALUSIAN CHRONIC MYELOID LEUKEMIA GROUP (GALMC) IN THE DISCONTINUATION OF THE TYROSINE KINASE INHIBITOR TREATMENT OUTSIDE OF CLINICAL TRIALS

Autor:	J.A. Vera Goñi, A Jiménez Morales, Y. Moatassim de la Torre, M.J. García Pérez, M. Jurado Chacón, P. López Garrido, M.I. Montero Cuadrado, M.I. Mata Vázquez, L. Hermosín Ramos, C. Ferrer Chaves, M.J. Ramírez Sánchez, M. Anguita Arance, Á. Mellado Gázquez, J.M. Puerta Puerta, C Alarcon-Payer
Rok vydání:	2019
Předmět:	Clinical trial Oncology medicine.medical_specialty business.industry medicine.drug_class Internal medicine medicine Myeloid leukemia Hematology business Tyrosine-kinase inhibitor Discontinuation
Zdroj:	HemaSphere. 3:884
ISSN:	2572-9241
DOI:	10.1097/01.hs9.0000566276.44891.74
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8684a73a7ee944f67aef357c005233c8 https://doi.org/10.1097/01.hs9.0000566276.44891.74 Zobrazit plný text záznamu Plný text